EBV+ nTNKLENKTL,使MIF

Siyu Qian1,2, Zeyuan Wang3, Yue Zhang1,2

  • 1Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Frontiers in immunology
|February 27, 2026
PubMed
概括

埃普斯坦-巴尔病毒 (EBV) 阳性结节T/NK细胞淋巴瘤 (EBV+ nTNKL) 在瘤微环境和细胞相互作用方面与ENKTL显著不同. 这项研究揭示了不同的免疫特征和信号通路,为这些罕见淋巴瘤提供了亚型特定疗法.